Clinical Trials : Chronic Inflammatory Demyelinating Polyneuropathy


Completed	: Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) : Demyelinating Diseases Paraproteinemias : 1999-11-03 : Drug: intravenous immunoglobulin (IVIg)
Completed	: Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) : Polyradiculoneuropathy, Chronic Inflammatory Demyelinating : 2005-09-13 : Drug: Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified
Terminated	: Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP : Chronic Inflammatory Demyelinating Polyradiculoneuropathy : 2010-10-06 : Drug: NewGam 10% Loading dose
Withdrawn	: Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) : Chronic Inflammatory Demyelinating Neuropathy : 2012-12-06 : Drug: Alemtuzumab infusion
Completed	: Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy : CIDP : 2015-12-10 : Other: CIDP treated (IVIG) usual treatment with intravenous immunoglobulin
Completed	: Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients : Pediatric Chronic Inflammatory Demyelinating Polyneuropathy : 2025-08-03 : PANZYGA is a human immunoglobin solution with 10% protein content for intravenous (IV) administration.